X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (78118) 78118
Newspaper Article (3984) 3984
Newsletter (3094) 3094
Book Chapter (216) 216
Magazine Article (177) 177
Web Resource (99) 99
Transcript (75) 75
Book / eBook (67) 67
Dissertation (54) 54
Conference Proceeding (42) 42
Trade Publication Article (42) 42
Publication (38) 38
Reference (9) 9
Government Document (6) 6
Book Review (5) 5
Streaming Video (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (55189) 55189
lung cancer (32837) 32837
male (32318) 32318
oncology (31814) 31814
female (30941) 30941
middle aged (27198) 27198
aged (24422) 24422
cancer (23498) 23498
lung neoplasms - pathology (18871) 18871
adult (16595) 16595
prognosis (13365) 13365
tumors (13162) 13162
metastasis (12993) 12993
research (12273) 12273
chemotherapy (12249) 12249
lung cancer, non-small cell (11676) 11676
lung-cancer (10449) 10449
expression (9356) 9356
care and treatment (9269) 9269
lung neoplasms - genetics (9148) 9148
aged, 80 and over (9125) 9125
animals (8874) 8874
carcinoma, non-small-cell lung - pathology (8422) 8422
carcinoma, squamous cell - pathology (8240) 8240
cancer therapies (7937) 7937
lung neoplasms - drug therapy (7856) 7856
carcinoma (7673) 7673
neoplasm staging (7617) 7617
analysis (7572) 7572
respiratory system (7539) 7539
genetic aspects (7358) 7358
gene expression (7286) 7286
survival (7238) 7238
apoptosis (6957) 6957
adenocarcinoma (6860) 6860
health aspects (6796) 6796
surgery (6787) 6787
proteins (6643) 6643
immunohistochemistry (6592) 6592
squamous cell carcinoma (6469) 6469
lung neoplasms - metabolism (6398) 6398
medical prognosis (6392) 6392
patients (6339) 6339
mutation (6244) 6244
cell line, tumor (6171) 6171
lung neoplasms - mortality (6100) 6100
pathology (5895) 5895
non-small cell lung cancer (5818) 5818
diagnosis (5686) 5686
risk factors (5671) 5671
adenocarcinoma - pathology (5668) 5668
lung neoplasms - surgery (5575) 5575
retrospective studies (5393) 5393
carcinoma, non-small-cell lung - drug therapy (5360) 5360
development and progression (5324) 5324
mice (5149) 5149
studies (5114) 5114
oncology, experimental (5087) 5087
lung neoplasms - diagnosis (4968) 4968
cell lung-cancer (4967) 4967
cell biology (4960) 4960
treatment outcome (4891) 4891
breast-cancer (4866) 4866
carcinoma, non-small-cell lung - genetics (4832) 4832
medicine & public health (4791) 4791
kinases (4579) 4579
biomarkers (4253) 4253
gene expression regulation, neoplastic (4240) 4240
survival rate (4161) 4161
squamous-cell carcinoma (4153) 4153
medicine (4137) 4137
breast cancer (3936) 3936
research article (3892) 3892
survival analysis (3861) 3861
non-small cell lung carcinoma (3834) 3834
medical research (3821) 3821
carcinoma, non-small-cell lung - mortality (3761) 3761
carcinoma, squamous cell - genetics (3721) 3721
smoking (3706) 3706
genes (3694) 3694
radiotherapy (3643) 3643
metastases (3539) 3539
biochemistry & molecular biology (3462) 3462
lung (3432) 3432
immunotherapy (3397) 3397
antineoplastic combined chemotherapy protocols - therapeutic use (3376) 3376
carcinoma, squamous cell - surgery (3334) 3334
follow-up studies (3301) 3301
hematology, oncology and palliative medicine (3257) 3257
cell proliferation (3255) 3255
medicine, research & experimental (3228) 3228
antineoplastic agents - therapeutic use (3170) 3170
carcinoma, non-small-cell lung - metabolism (3169) 3169
multidisciplinary sciences (3139) 3139
cancer research (3087) 3087
signal transduction (3019) 3019
clinical trials (3016) 3016
cell cycle (3004) 3004
carcinoma, squamous cell - drug therapy (3000) 3000
lung neoplasms - diagnostic imaging (2993) 2993
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (12) 12
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Online Resources - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
West Park Healthcare Centre - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Scarborough Hospital - General (1) 1
Scarborough Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (81084) 81084
Japanese (2676) 2676
Chinese (1142) 1142
German (632) 632
Russian (618) 618
French (607) 607
Spanish (319) 319
Italian (208) 208
Polish (177) 177
Korean (104) 104
Portuguese (65) 65
Turkish (51) 51
Romanian (29) 29
Czech (24) 24
Croatian (19) 19
Hungarian (18) 18
Danish (17) 17
Dutch (12) 12
Lithuanian (10) 10
Finnish (9) 9
Bulgarian (6) 6
Norwegian (6) 6
Hebrew (5) 5
Ukrainian (5) 5
Serbian (4) 4
Slovak (4) 4
Swedish (4) 4
Slovenian (3) 3
Icelandic (2) 2
Latvian (2) 2
Persian (2) 2
Arabic (1) 1
Breton (1) 1
Greek (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Campbell, Joshua D and Yau, Christina and Bowlby, Reanne and Liu, Yuexin and Brennan, Kevin and Fan, Huihui and Taylor, Alison M and Wang, Chen and Walter, Vonn and Akbani, Rehan and Byers, Lauren Averett and Creighton, Chad J and Coarfa, Cristian and Cherniack, Andrew D and Gevaert, Olivier and Prunello, Marcos and Shen, Hui and Chen, Jianhong and Cheng, Hui and Hayes, D. Neil and Bullman, Susan and Pedamallu, Chandra Sekhar and Ojesina, Akinyemi I and Mungall, Karen L and Hegde, Apurva and Diao, Lixia and Ma, Wencai and Sumazin, Pavel and Chen, Ting-Wen and Zuna, Rosemary and Al-Ahmadie, Hikmat and Zhou, Jane H and Drill, Esther and Wong, Christopher K and Stuart, Joshua M and Laird, Peter W and Hoadley, Katherine A and Weinstein, John N and Peto, Myron and Pickering, Curtis R and Chen, Zhong and Van Waes, Carter and Caesar-Johnson, Samantha J and Ferguson, Martin L and Tarnuzzer, Roy and Wang, Zhining and Zenklusen, Jean C and Chudamani, Sudha and Liu, Jia and Lolla, Laxmi and Naresh, Rashi and Pihl, Todd and Wan, Yunhu and Wu, Ye and Cho, Juok and DeFreitas, Timothy and Frazer, Scott and Gehlenborg, Nils and Getz, Gad and Kim, Jaegil and Lawrence, Michael S and Lin, Pei and Noble, Michael S and Saksena, Gordon and Voet, Doug and Chambwe, Nyasha and Dhankani, Varsha and Knijnenburg, Theo and Kramer, Roger and Leinonen, Kalle and Miller, Michael and Reynolds, Sheila and Hegde, Apurva M and Ju, Zhenlin and Korkut, Anil and Li, Jun and Liang, Han and Ling, Shiyun and Lu, Yiling and Mills, Gordon B and Ng, Kwok-Shing and Rao, Arvind and Abeshouse, Adam and Armenia, Joshua and Chakravarty, Debyani and de Bruijn, Ino and Gao, Jianjiong and Gross, Benjamin E and Heins, Zachary J and Kundra, Ritika and La, Konnor and Ladanyi, Marc and Luna, Augustin and Nissan, Moriah G and Ochoa, Angelica and Sanchez-Vega, Francisco and Sander, Chris and Schultz, Nikolaus and Sumer, S. Onur and Sun, Yichao and ... and The Cancer Genome Atlas Research Network and Canc Genome Atlas Res Network and Cancer Genome Atlas Research Network and Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Cell reports (Cambridge), ISSN 2211-1247, 2018, Volume 23, Issue 1, pp. 194 - 212.e6
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2015, Volume 373, Issue 2, pp. 123 - 135
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2015, Volume 10, Issue 8, p. e0136023
.... First clinical trials with therapies targeting the programmed cell death receptor PD-1 and its ligand PD-L1 have shown promising results in several solid tumors... 
CELL LUNG-CANCER | TUMOR-INFILTRATING LYMPHOCYTES | INTERLEUKIN-2 | GEFITINIB | IMPACT | MULTIDISCIPLINARY SCIENCES | ANTIBODY | B7-H1 | T-CELLS | CHEMOTHERAPY | LIGAND 1 EXPRESSION | Adenocarcinoma - pathology | Prognosis | Follow-Up Studies | Lung Neoplasms - mortality | Carcinoma, Large Cell - pathology | Carcinoma, Squamous Cell - metabolism | Carcinoma, Squamous Cell - pathology | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Male | Carcinoma, Large Cell - mortality | Immunoenzyme Techniques | Adenocarcinoma - metabolism | Carcinoma, Squamous Cell - mortality | Neoplasm Grading | Biomarkers, Tumor - metabolism | Female | Retrospective Studies | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Large Cell - metabolism | Carcinoma, Non-Small-Cell Lung - metabolism | Carcinoma, Squamous Cell - therapy | Programmed Cell Death 1 Receptor - metabolism | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | B7-H1 Antigen - metabolism | Carcinoma, Non-Small-Cell Lung - therapy | Adenocarcinoma - therapy | Aged | Neoplasm Staging | Carcinoma, Large Cell - therapy | Adenocarcinoma - mortality | Care and treatment | Physiological aspects | Genetic aspects | Research | Lung cancer, Non-small cell | Apoptosis | Immunohistochemistry | Thoracic surgery | PD-1 protein | Lung cancer | Clinical trials | Oncology | Cancer therapies | Lymph nodes | Subgroups | Proteins | Rank tests | Regression models | Bcl-x protein | Lymphocytes | Immunotherapy | Medical research | Immunoglobulins | Squamous cell carcinoma | Cell survival | Cytokines | Hematology | Tumor cells | Non-small cell lung carcinoma | Breast cancer | Regression analysis | Patients | Medicine | Pathology | Chemotherapy | Hospitals | Cell death | Medical prognosis | PD-L1 protein | Ligands | Diagnostic systems | Solid tumors | Cancer | Tumors
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 21, pp. 2040 - 2051
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2016, Volume 375, Issue 19, pp. 1856 - 1867
Journal Article
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1236 - 1244
Summary Background With use of EGFR tyrosine-kinase inhibitor monotherapy for patients with activating EGFR mutation-positive non-small-cell lung cancer (NSCLC... 
Hematology, Oncology and Palliative Medicine | TRIAL | GROWTH-FACTOR RECEPTOR | CISPLATIN PLUS GEMCITABINE | PLACEBO | EFFICACY | NSCLC | ONCOLOGY | ADENOCARCINOMA | DOUBLE-BLIND | COMBINATION | CHEMOTHERAPY | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Confidence Intervals | Prognosis | Lung Neoplasms - mortality | Carcinoma, Squamous Cell - genetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Receptor, Epidermal Growth Factor - drug effects | Lung Neoplasms - pathology | Male | Bevacizumab | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized - administration & dosage | Carcinoma, Squamous Cell - mortality | Neoplasm Invasiveness - pathology | Female | Quinazolines - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Drug Administration Schedule | Carcinoma, Non-Small-Cell Lung - genetics | Japan | Kaplan-Meier Estimate | Treatment Outcome | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Maximum Tolerated Dose | Carcinoma, Squamous Cell - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Development and progression | Care and treatment | Cross infection | Nosocomial infections | Erlotinib | Lung cancer, Non-small cell
Journal Article